Your browser doesn't support javascript.
loading
Stable nebulization and muco-trapping properties of regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19.
McSweeney, Morgan D; Stewart, Ian; Richardson, Zach; Kang, Hyunah; Park, Yoona; Kim, Cheolmin; Tiruthani, Karthik; Wolf, Whitney; Schaefer, Alison; Kumar, Priya; Aurora, Harendra; Hutchins, Jeff; Cho, Jong Moon; Hickey, Anthony J; Lee, Soo Young; Lai, Samuel K.
Afiliação
  • McSweeney MD; Inhalon Biopharma Inc Research Triangle Park North Carolina USA.
  • Stewart I; Mucommune LLC Research Triangle Park North Carolina USA.
  • Richardson Z; RTI International Research Triangle Park North Carolina USA.
  • Kang H; Inhalon Biopharma Inc Research Triangle Park North Carolina USA.
  • Park Y; Mucommune LLC Research Triangle Park North Carolina USA.
  • Kim C; Biotechnology Research Institute Celltrion Inc Incheon Republic of Korea.
  • Tiruthani K; Biotechnology Research Institute Celltrion Inc Incheon Republic of Korea.
  • Wolf W; Biotechnology Research Institute Celltrion Inc Incheon Republic of Korea.
  • Schaefer A; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina-Chapel Hill Chapel Hill North Carolina USA.
  • Kumar P; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina-Chapel Hill Chapel Hill North Carolina USA.
  • Aurora H; UNC/NCSU Joint Department of Biomedical Engineering University of North Carolina-Chapel Hill Chapel Hill North Carolina USA.
  • Hutchins J; Department of Anesthesiology, School of Medicine University of North Carolina Chapel Hill North Carolina USA.
  • Cho JM; Department of Anesthesiology, School of Medicine University of North Carolina Chapel Hill North Carolina USA.
  • Hickey AJ; Inhalon Biopharma Inc Research Triangle Park North Carolina USA.
  • Lee SY; Biotechnology Research Institute Celltrion Inc Incheon Republic of Korea.
  • Lai SK; RTI International Research Triangle Park North Carolina USA.
Bioeng Transl Med ; : e10391, 2022 Aug 30.
Article em En | MEDLINE | ID: mdl-36248234

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Bioeng Transl Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Bioeng Transl Med Ano de publicação: 2022 Tipo de documento: Article